Literature DB >> 1797088

Clear cell sarcoma with t(12;22) (q13-14;q12).

P Peulvé1, C Michot, J P Vannier, P Tron, J Hemet.   

Abstract

Karyotypic analysis of a clear cell sarcoma revealed a translocation t(12;22) (q13-14;q12) as a primary chromosomal change. This case is the third clear cell sarcoma cytogenetically analyzed; the two previously reported cases had t(12;22)(p11;p11), and a complex karyotype with trisomy 22, respectively.

Entities:  

Mesh：

Year:  1991        PMID： 1797088     DOI： 10.1002/gcc.2870030512

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


  4 in total

1.  A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.

Authors:  U Yamaguchi; T Hasegawa; Y Morimoto; U Tateishi; M Endo; F Nakatani; A Kawai; H Chuman; Y Beppu; M Endo; H Kurotaki; K Furuta
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Authors:  Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

3.  Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.

Authors:  C Orndal; N Mandahl; A Rydholm; H Willén; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).

Authors:  S M Langezaal; J F Graadt van Roggen; A M Cleton-Jansen; J J Baelde; P C Hogendoorn
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.